Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of British Columbia

$741,565.00

Regulation of retromer in health and disease

EF 2015-16

Résumé
Every cell is like a busy city: it has to coordinate information flow, perform thousands of different tasks, and move materials, like fats and proteins, to where they are needed. Like cities, cells have a complex internal transportation system that controls traffic. This system works well most of the time, but can get disrupted, and persistent disruptions can cause dysfunction and disease. This project focuses on an important part of this cellular transportation system called "retromer". Problems with retromer cause neurological disorders such as Parkinson's and Alzheimer's disease, but to develop effective treatments for these conditions, we first need to understand the fundamental causes of disease. Many of the traffic signals and pathways linked to human disease are also found in yeast, a simple one-celled organism. Studying retromer in yeast allows us to use different genome-wide technologies to uncover pathways and machinery on a very large scale and allows us to make discoveries that would be difficult or impossible in complex organisms. In fact, retromer was first discovered in yeast, and many important discoveries about retromer are still being made in this cell system. Recently, we discovered that a family of "VPS9-like" proteins regulates retromer assembly in yeast. One of these proteins, called "VARP", was also found to be important for retromer function in human cells. This gives us the unparalleled opportunity to use yeast to study VARP and establish exactly how it regulates retromer. Once we have made discoveries in yeast, we can transfer this knowledge to the study of cells from mice or humans to test if increasing VARP function can overcome the retromer defects seen in Parkinson's or Alzheimer's disease. In the longer term, our research is expected to identify new drug targets that will help in the development of new treatments for these neurodegenerative disorders.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
345787
Name
Conibear Elizabeth
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Regulation of retromer in health and disease
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$741,565
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Endosome; Golgi Complex; Parkinson'S Disease; Protein Trafficking; Rab Gtp Exchange Factor; Retromer; Vesicle Transport; Yeast Genetics
Abstract
Every cell is like a busy city: it has to coordinate information flow, perform thousands of different tasks, and move materials, like fats and proteins, to where they are needed. Like cities, cells have a complex internal transportation system that controls traffic. This system works well most of the time, but can get disrupted, and persistent disruptions can cause dysfunction and disease. This project focuses on an important part of this cellular transportation system called "retromer". Problems with retromer cause neurological disorders such as Parkinson's and Alzheimer's disease, but to develop effective treatments for these conditions, we first need to understand the fundamental causes of disease. Many of the traffic signals and pathways linked to human disease are also found in yeast, a simple one-celled organism. Studying retromer in yeast allows us to use different genome-wide technologies to uncover pathways and machinery on a very large scale and allows us to make discoveries that would be difficult or impossible in complex organisms. In fact, retromer was first discovered in yeast, and many important discoveries about retromer are still being made in this cell system. Recently, we discovered that a family of "VPS9-like" proteins regulates retromer assembly in yeast. One of these proteins, called "VARP", was also found to be important for retromer function in human cells. This gives us the unparalleled opportunity to use yeast to study VARP and establish exactly how it regulates retromer. Once we have made discoveries in yeast, we can transfer this knowledge to the study of cells from mice or humans to test if increasing VARP function can overcome the retromer defects seen in Parkinson's or Alzheimer's disease. In the longer term, our research is expected to identify new drug targets that will help in the development of new treatments for these neurodegenerative disorders.
Competitiondate
201603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Conibear, Elizabeth
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $741,565~ $0~